re: Ann: Full Year Results, Appendix 4E and A... I know that the market sold down CSL today, but here is my summary of the financials.
1. EBIT margin of 29%
2. NOPAT margin of 24%
3. EPS $2.44 (up 26% due to buybacks)
4. Gearing is 23%
5. R & D is $427m - up 16%
6. For every $1 of revenue, 26c is FCF (which is quite good).
7. Potentially another share buyback.
HT1
Ann: Full Year Results, Appendix 4E and Analysts , page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.65 |
Change
-0.280(0.09%) |
Mkt cap ! $149.1B | |||
| Open | High | Low | Value | Volume |
| $309.31 | $309.89 | $307.40 | $80.90M | 277.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 45 | $307.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.67 | 11 | 2 |
View Market Depth
| Last trade - 13.03pm 30/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |